Search results
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via AOL· 6 days ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 2 days agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 3 days agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance via AOL· 2 days agoWhile Novavax's vaccine did finally reach the market in mid-2022 targeting the booster market, it...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 2 days agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 2 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga· 2 days agoNovavax has a sole license to its adjuvanted COVID-19 vaccine for use in combination with Sanofi’s...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 2 days agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize...
Benzinga· 3 days agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines ...